Cargando...
Review of the COVID-19 Risk in Multiple Sclerosis
The ongoing pandemic of the novel coronavirus of 2019 (COVID-19) has resulted in over 1 million deaths, primarily affecting older patients with chronic ailments. Multiple sclerosis (MS) patients have been deemed particularly vulnerable given their high rates of disability and increased susceptibilit...
Guardado en:
| Publicado en: | J Cell Immunol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098748/ https://ncbi.nlm.nih.gov/pubmed/33959727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.33696/immunology.3.080 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|